Skip to main content

Table 2 Demographic characteristics of antiretroviral-naïve HIV+ patients initiating atazanavir-containing vs. atazanavir-free regimens

From: Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study

  Commercial Database Medicaid Database
  ATV-Containing Regimen
N = 2,437
ATV-Free Regimen
N = 19,774
p-value ATV-Containing Regimen
N = 1,505
ATV-Free Regimen
N = 5,631
p-value
  N % N %   N % N %  
Age in Years (Mean, SD) 41.0 10.2 40.4 10.5 0.0055 41.2 10.9 41.3 11.2 0.6919
Male 1,863 76.4 % 16,566 83.8 % <.0001 746 49.6 % 2,883 51.2 % 0.2282
Regiona
 Northeast 439 18.0 % 3,146 15.9 % 0.0002      
 North Central 290 11.9 % 2,896 14.6 %       
 South 1,229 50.4 % 10,174 51.5 %       
 West 440 18.1 % 3,300 16.7 %       
 Unknown 39 1.6 % 258 1.3 %       
Raceb
 White       206 13.7 % 964 17.1 % 0.0153
 Black       1,088 72.3 % 3,894 69.2 %  
 Hispanic       16 1.1 % 76 1.3 %  
 Other       13 0.9 % 62 1.1 %  
 Unknown/Missing       182 12.1 % 635 11.3 %  
Capitationc 548 22.5 % 3,754 19.0 % <.0001 609 40.5 % 2,256 40.1 % 0.7779
  1. ATV atazanavir, SD standard deviation
  2. aCommercial population only; bMedicaid population only; cPresence of claim with capitated payment arrangement